Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NI | U |
|---|---|---|
| Price | $39.13 | $43.03 |
| Change today | ▲ 0.33% | ▲ 5.13% |
| Market cap | $18.77B | $18.94B |
| Return, 3 months | -15.9% | +42.5% |
| Return, year to date | -4.4% | -2.6% |
| Return, 1 year | -6.7% | +12.3% |
| P/E (TTM) | 20.8 | -31.6 |
| P/B | 2.0 | 6.2 |
| P/E percentile vs own 5y | – | 25th |
| Dividend yield | 2.96% | – |
| Revenue growth (YoY, latest qtr) | – | +23.9% |
| Net profit growth (YoY) | – | +78.9% |
| Gross margin | – | 64.9% |
| Operating margin | – | -30.4% |
| Net margin | – | -29.0% |
| Return on equity | – | -18.9% |
| Analyst target vs. price | +26.9% | +13.2% |
| Analyst buy share | 90% | 88% |
| RSI (14) | 30 | 47 |
| 30-day volatility | 14.5% | 37.8% |
| Max drawdown, 1 year | -20.0% | -65.4% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
